Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MTAC

MedTech Acquisition (MTAC) Stock Price, News & Analysis

MedTech Acquisition logo

About MedTech Acquisition Stock (NASDAQ:MTAC)

Advanced Chart

Key Stats

Today's Range
$8.96
$12.83
50-Day Range
$9.34
$11.34
52-Week Range
$8.43
$12.83
Volume
183,276 shs
Average Volume
9,656 shs
Market Capitalization
$83.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

Receive MTAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

MTAC Stock News Headlines

Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
SMTI Sanara MedTech Inc.
See More Headlines

MTAC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that MedTech Acquisition investors own include Ginkgo Bioworks (DNA), BYD (BYDDY), Spire Global (SPIR), Altimeter Growth (AGC), ARK Innovation ETF (ARKK), Berkshire Hathaway (BRK.B) and Coinbase Global (COIN).

Company Calendar

Today
5/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:MTAC
Web
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.89 per share
Price / Cash Flow
12.80
Book Value
($2.04) per share
Price / Book
-5.56

Miscellaneous

Free Float
1,952,000
Market Cap
$83.80 million
Optionable
Not Optionable
Beta
-0.04
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:MTAC) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners